Wednesday , December 13 2017
Home / Resources / Clinical Presentations / The Present and Future of Insulin Therapy Part 7

The Present and Future of Insulin Therapy Part 7

 

In this week’s Homerun Slides, incretins, an explanation of the glucose-stimulated secretion of insulin and the effect of exenatide versus glargine insulin on insulin secretion in type 2 diabetes…

Catch up on past Homerun Slides for The Present and Future of Insulin Therapy series.

To download part 6, click here: The Present and Future of Insulin Therapy in the Era of Pathophysiologic Treatment of T2DM, Part 6

To download part 5, click here: The Present and Future of Insulin Therapy in the Era of Pathophysiologic Treatment of T2DM, Part 5

To download part 4 and for links to parts 1 through 3, click here: The Present and Future of Insulin Therapy in the Era of Pathophysiologic Treatment of T2DM, Part 4

To download part 3, click here: The Present and Future of Insulin Therapy in the Era of Pathophysiologic Treatment of T2DM, Part 3

To download part 2, click here: The Present and Future of Insulin Therapy in the Era of Pathophysiologic Treatment of T2DM, Part 2

To download part 1, click here: The Present and Future of Insulin Therapy in the Era of Pathophysiologic Treatment of T2DM, Part 1